Skip to main content

Advertisement

Table 2 FDA-approved antiviral and combinations for HCV treatment in different genotypes

From: Hepatitis C virus management: potential impact of nanotechnology

Genotype Drug PEG-IFN RBV Boceprevir Telaprevir Simeprevir Sofosbuvir Ledipasvir Ombitasvir Paritaprevir/ Ritonavir Dasabuvir
1, 2, 3, 6 PEG-IFN           
1, 2, 3, 6 RBV          
1 Boceprevir         
1 Telaprevir         
1 Simeprevir         
1, 4 Sofosbuvir         
2, 3           
1           
1 Ledipasvir           
1 Ombitasvir         
1         
4 Paritaprevir/Ritonavir           
3 Dasabuvir           
  1. Abbreviations: PEG-IFN pegylated interferon, RBV ribavirin